XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
This piece outlines scenarios where a lifecycle fund may be preferable to a target date fund, helping you tailor your retirement strategy.
23,259 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Sam Altman cautions that some companies are blaming AI for layoffs that were planned for other reasons, a trend with ...
Texas homeowners face steep local taxes even as the state has no income tax. Fort Bend County tops the list with an e...
Bitdeer, the largest bitcoin miner by hashrate, liquidated a significant portion of its BTC holdings this week, drivi...
Five U.S. tech giants have $662 billion in future data-center leases not yet begun, a hidden liability Moody’s says c...
Institutional traders are piling into XRP spot buying while the futures market cools, signaling a pivot in market par...
Warren Buffett hands the CEO role to Greg Abel, shifting Berkshire Hathaway's guard and fueling a debate about whethe...
A growing share of crypto wealth sits behind private keys. With no centralized backstop, 2026 could reveal the first ...
Retail investors are stepping back even as institutional ETFs accumulate more Bitcoin. The latest on-chain signals hi...
A weekend strike campaign put the U.S. on center stage as China and Russia offered only verbal condemnations. Markets...
Seven REITs cleared a strict financial screen, delivering dividends as high as 6.27% and drawing investor attention a...
Amid rising tensions with Iran, the White House insists U.S. munitions stockpiles are robust, even as Democrats warn ...